Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 15;146(8):2122-2129.
doi: 10.1002/ijc.32541. Epub 2019 Jul 13.

A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density

Affiliations

A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density

Adam R Brentnall et al. Int J Cancer. .

Abstract

Panels of single nucleotide polymorphisms (SNPs) stratify risk for breast cancer in women from the general population, but studies are needed assess their use in a fully comprehensive model including classical risk factors, mammographic density and more than 100 SNPs associated with breast cancer. A case-control study was designed (1,668 controls, 405 cases) in women aged 47-73 years attending routine screening in Manchester UK, and enrolled in a wider study to assess methods for risk assessment. Risk from classical questionnaire risk factors was assessed using the Tyrer-Cuzick model; mean percentage visual mammographic density was scored by two independent readers. DNA extracted from saliva was genotyped at selected SNPs using the OncoArray. A predefined polygenic risk score based on 143 SNPs was calculated (SNP143). The odds ratio (OR, and 95% confidence interval, CI) per interquartile range (IQ-OR) of SNP143 was estimated unadjusted and adjusted for Tyrer-Cuzick and breast density. Secondary analysis assessed risk by oestrogen receptor (ER) status. The primary polygenic risk score was well calibrated (O/E OR 1.10, 95% CI 0.86-1.34) and accuracy was retained after adjustment for Tyrer-Cuzick risk and mammographic density (IQ-OR unadjusted 2.12, 95% CI% 1.75-2.42; adjusted 2.06, 95% CI 1.75-2.42). SNP143 was a risk factor for ER+ and ER- breast cancer (adjusted IQ-OR, ER+ 2.11, 95% CI 1.78-2.51; ER- 1.81, 95% CI 1.16-2.84). In conclusion, polygenic risk scores based on a large number of SNPs improve risk stratification in combination with classical risk factors and mammographic density, and SNP143 was similarly predictive for ER-positive and ER-negative disease.

Keywords: SNPs; Tyrer-Cuzick; breast cancer; breast density; risk prediction; risk stratification.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Calibration of the primary polygenic risk score (unadjusted). Points are observed and expected odds ratios by decile, the fit from a logistic regression (—) is also shown (see Supporting Information Table S3). O/E OR: a calibration coefficient for the observed (O) divided by expected (E) odds ratio (OR), or fitted slope of the line (—).
Figure 2
Figure 2
Calibration (95% CI) of the primary polygenic risk score (unadjusted) split into subscores of 20 SNPs ordered by the overview p‐value for each SNP (1 = top 20 [SNP1–20] predictive SNPs, 2 = next 20 [SNP21–40], similarly 3–6 and 7 = least predictive SNPs [SNP121–143]).

Similar articles

Cited by

References

    1. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879–86. - PubMed
    1. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction. Cancer 1994;73:643–51. - PubMed
    1. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004;23:1111–30. - PubMed
    1. Tice JA, Cummings SR, Smith‐Bindman R, et al. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008;148:337–47. - PMC - PubMed
    1. Lee AJ, Cunningham AP, Tischkowitz M, et al. Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model. Genet Med 2016;18:1190–8. - PMC - PubMed

Publication types